Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Pharmaceuticals,
Год журнала:
2024,
Номер
17(10), С. 1354 - 1354
Опубликована: Окт. 10, 2024
Metabolic-Associated
Fatty
Liver
Disease
(MAFLD)
is
a
clinical-pathological
scenario
that
occurs
due
to
the
accumulation
of
triglycerides
in
hepatocytes
which
considered
significant
cause
liver
conditions
and
contributes
an
increased
risk
death
worldwide.
Even
though
possible
causes
MAFLD
can
involve
interaction
genetics,
hormones,
nutrition,
lifestyle
(diet
sedentary
lifestyle)
most
influential
factor
developing
this
condition.
Polyphenols
comprise
many
natural
chemical
compounds
be
helpful
managing
metabolic
diseases.
Therefore,
aim
review
was
investigate
impact
oxidative
stress,
inflammation,
mitochondrial
dysfunction,
role
polyphenols
MAFLD.
Some
reverse
part
damage
related
or
among
them
are
anthocyanin,
baicalin,
catechin,
curcumin,
chlorogenic
acid,
didymin,
epigallocatechin-3-gallate,
luteolin,
mangiferin,
puerarin,
punicalagin,
resveratrol,
silymarin.
These
have
actions
reducing
plasma
enzymes,
body
mass
index,
waist
circumference,
adipose
visceral
indices,
lipids,
glycated
hemoglobin,
insulin
resistance,
HOMA
index.
They
also
reduce
nuclear
factor-KB
(NF-KB),
interleukin
(IL)-1β,
IL-6,
tumor
necrosis
factor-α
(TNF-α),
blood
pressure,
fat
content,
steatosis
fibrosis.
On
other
hand,
they
improve
HDL-c,
adiponectin
levels,
fibrogenesis
markers.
results
show
promising
prevention
treatment
Язык: Английский
Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases
Annals of Hepatology,
Год журнала:
2025,
Номер
unknown, С. 101900 - 101900
Опубликована: Март 1, 2025
Aminotransferases,
particularly
alanine
aminotransferase
(ALT),
are
commonly
used
in
the
detection,
diagnosis,
and
management
of
chronic
liver
diseases.
ALT,
a
sensitive
cost-effective
marker
injury,
remains
pivotal
predicting
clinical
outcomes
guiding
interventions
several
diseases
including
metabolic
dysfunction-associated
steatotic
disease,
viral
hepatitis.
This
study
aims
to
explore
evolving
role
ALT
as
biomarker.
A
comprehensive
review
evidence
was
conducted,
focusing
on
studies
evaluating
thresholds,
diagnostic
accuracy,
integration
with
non-invasive
assessment
tools.
Special
emphasis
given
novel
approaches,
artificial
intelligence-driven
algorithms.
Expert
opinions
from
hepatology
care
perspectives
were
considered
assess
practical
implications
refining
ALT-based
strategies.
levels
influenced
by
diverse
factors
such
age,
gender,
risks,
challenging
use
specific
thresholds
biomarker
disease
prognosis.
Emerging
suggests
redefining
ranges
enhance
sensitivity
accuracy
detecting
abnormalities.
The
advanced
tools,
intelligence,
patient
assessments
can
optimize
early
detection
thus
reducing
underdiagnosis,
asymptomatic
or
vulnerable
populations.
work
highlights
urgency
tailor
approaches
primary
specialized
care,
ensuring
timely
targeted
intervention
effectively
address
global
burden
Язык: Английский
Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults
Diabetes/Metabolism Research and Reviews,
Год журнала:
2024,
Номер
40(8)
Опубликована: Ноя. 1, 2024
ABSTRACT
Aims
This
study
investigated
the
association
of
postprandial
plasma
glucose
(PPG)
with
cancer
mortality
using
a
general
cohort
US
adults.
Materials
and
Methods
included
14,860
adults
who
attended
third
National
Health
Nutrition
Examination
Survey
from
1988
to
1994,
being
followed
up
until
December
31,
2019.
The
explanatory
variable
was
level
glucose,
including
PPG
fasting
time
0–3.9
h
(PPG
0–3.9h
)
4–7.9
4–7.9h
),
≥8
(PG
at
2
after
oral
tolerance
test
2hOGTT
).
Plasma
glucose‐associated
risk
assessed
Cox
proportional
hazard
models.
Results
A
1‐natural‐log‐unit
increase
in
associated
higher
multivariate‐adjusted
for
[hazard
ratio
(HR),
3.24;
95%
confidence
interval
(CI),
1.50–7.00].
However,
,
PG
haemoglobin
1c
insulin
were
not
significantly
mortality.
positive
remained
those
without
prior
diagnosis
cancer.
Conclusions
High
is
Lowering
may
reduce
Язык: Английский
Editor-in-Chief articles of choice and comments from January to June 2024
World Journal of Gastroenterology,
Год журнала:
2024,
Номер
30(34), С. 3875 - 3882
Опубликована: Сен. 8, 2024
As
the
Editor-in-Chief
of
Язык: Английский
Cytokeratin 18 in nonalcoholic fatty liver disease: value and application
Expert Review of Molecular Diagnostics,
Год журнала:
2024,
Номер
unknown, С. 1 - 14
Опубликована: Окт. 10, 2024
Introduction
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
a
common
metabolism-related
worldwide.
Although
studies
have
shown
that
some
medications
may
be
effective
for
treating
NAFLD,
they
do
not
satisfy
the
medical
requirements,
and
lifestyle
changes
are
most
basic
strategy.
Thus,
early
detection
of
NAFLD
timely
interventions
highly
important.
Язык: Английский